1. Parkinsonism—Drug Treatment: Part I
- Author
-
Toni Host, Mary J. Berg, Debra K. Willis, Barbara E. Ebert, Richard W. Fincham, and Dorothy D. Schottelius
- Subjects
030110 physiology ,0301 basic medicine ,medicine.medical_specialty ,medicine.medical_treatment ,Disease ,Anticholinergic agents ,030226 pharmacology & pharmacy ,Antiparkinson Agents ,03 medical and health sciences ,Drug treatment ,0302 clinical medicine ,Pharmacotherapy ,Dopamine ,medicine ,Humans ,Pharmacology (medical) ,General Pharmacology, Toxicology and Pharmaceutics ,Intensive care medicine ,Chemotherapy ,business.industry ,Parkinsonism ,Parkinson Disease ,medicine.disease ,Surgery ,business ,medicine.drug - Abstract
The purpose of this two-part review is to explain current drug treatment in part I and discuss investigational drug therapy and miscellaneous drugs in the management of parkinsonism in part II. The medical approach to this disease is still based on the imbalance between a deficiency of dopamine and a functional increase in acetylcholine. Anticholinergic agents are used to treat the tremors in the early stages of the disease.
- Published
- 1987
- Full Text
- View/download PDF